
Loading, please wait...

Loading, please wait...

Recent research utilizing proteomics-guided exome re-analysis has identified a novel LEMD2 muscular dystrophy phenotype. This condition arises from bi-allelic variants in the LEMD2 gene, which encodes a critical protein of the inner nuclear membrane. Clinicians traditionally associated mutations in this gene with progeroid syndromes and severe cardiomyopathies. However, this study significantly broadens the clinical spectrum of nuclear envelopathies. Specifically, the LEMD2 protein plays a vital role in maintaining the integrity of the nuclear envelope. It also helps in regulating chromatin organization within the cell nucleus. Consequently, when bi-allelic variants occur, nuclear instability develops. Therefore, this leads to the progressive muscle weakness characteristic of muscular dystrophy.
This discovery highlights the importance of re-evaluating negative genetic data through advanced proteomics. Furthermore, identifying the specific genetic basis of a patient's condition allows for more accurate family counseling. While previous cases of LEMD2 mutations focused on cardiac or aging-related symptoms, neurologists should now consider this gene for unexplained muscle weakness. Additionally, understanding these molecular pathways may pave the way for future gene therapies. Similarly, this research suggests that the genotype-phenotype map for lamin-related genes remains incomplete. Moreover, clinicians in India can leverage these findings to improve diagnostic yields in complex neuromuscular cases. Ultimately, expanding the known genetic causes of dystrophy improves personalized patient care.
The LEMD2 protein is essential for maintaining the structural integrity of the nuclear envelope. It also organizes chromatin, ensuring the cell nucleus functions correctly across different tissues.
Previously, LEMD2 variants were linked mostly to progeria and heart disease. This research proves that bi-allelic variants can also cause a distinct muscular dystrophy phenotype, broadening the diagnostic scope for this gene.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Pauper M et al. A muscular dystrophy associated with bi-allelic LEMD2 variants: Expanding the genotype of nuclear envelopathies. Brain Pathol. 2026 Mar 03. doi: 10.1111/bpa.70082. PMID: 41776713.
Caravia XM et al. Loss of function of the nuclear envelope protein LEMD2 causes DNA damage-dependent cardiomyopathy. J Clin Invest. 2022;132(23):e158897. doi: 10.1172/JCI158897.
Kaufman C et al. LEMD2-associated progeroid syndrome: Expanding the phenotype of the nuclear envelopathy caused by a defect in LEMD2 gene. Aging Cell. 2024;23(8):e14189. doi: 10.1111/acel.14189.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Research identifies bi-allelic LEMD2 variants as a cause of a novel muscular dystrophy, expanding the known spectrum of rare nuclear envelopathies....
6 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today